Significant differences were found among women receiving mammography at a cancer center versus those visiting a mobile mammography van, according to an article published online ahead of print in the American Journal of Roentgenology (AJR). The print version is scheduled to be published in the December 2017 issue of AJR.

October 18, 2017 — HealthMyne announced the release of QIDS (Quantitative Imaging Decision Support) 3.0 with the Incidental Findings Workflow module, along with many other new features and enhancements. Incidental lesions are discovered in up to 30 percent of imaging studies, yet follow-up is generally poor. It is well known that the earlier cancer is detected, the higher the probability of long-term survival. Additionally, costs for cancer treatment increase dramatically when started in later stages of the disease.

October 18, 2017 — Magnetic resonance imaging (MRI)-based measurements of the functional connections in the brain can help predict long-term recovery in patients who suffer neurological disability after cardiac arrest, according to a clinical study appearing online in the journal Radiology.

October 18, 2017 — Carestream Health looks to make converting to digital radiography (DR) easy and affordable with the launch of its Carestream DRX-Transportable System/Lite. This system equips facilities to convert room-based or mobile imaging systems to DR through use of a wireless tablet PC that gives users complete control of the X-ray system and displays diagnostic images as they are acquired.

Carestream DRX-Transportable System/Lite

A machine learning tool can help identify which high-risk breast lesions are likely to become cancerous, according to a new study appearing online in the journal Radiology. Researchers said the technology has the potential to reduce unnecessary surgeries.

October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies.

October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful completion of the first gated treatment at the Proton Therapy Center in Trento, Italy.
 

Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the new eL18-4 transducer with full solution for 'small parts' assessment. These ultrasound exams detect abnormalities in the small organs that are close to the skin. The Philips Ultimate Small Parts Solution features four key innovations that work together to help improve patient care: the eL18-4 PureWave linear array transducer, Philips MicroFlow Imaging, Philips Elastography and Philips Precision Biopsy. The new eL18-4 transducer can also be used to assess musculoskeletal injuries.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now